(News4Utah) – More than 29 million people in the U.S. are living with diabetes. For patients, it’s essential to know your sugar levels throughout the day.
The U.S. Food and Drug Administration has approved the world’s first long-term Continuous Glucose Monitoring System.
It’s called the Eversense Continuous Glucose Monitoring system by Senseonics. It’s an implantable glucose sensor that lasts three months at a time.
“For people with Type 1, it’s a rare individual who would not benefit greatly from Continuous Glucose Monitoring and for 2018 and beyond it is the standard of care,” said Dr. Steven Edelman, Professor of Medicine at the University of California San Diego.
“This current system is another step along that path to less painful, less invasive, less intrusive technology that allows people to know their glucose levels and act on them,” said Dr. Timothy Bailey, Clinical Associate Professor at the University of California San Diego.
Doctors and patients say it’s an easy process that takes only a few minutes for each doctor’s visit.
“You have a very small sensor in just a few minutes in the doctor’s office it’s placed under the skin and heals up and you put over it a transmitter,” said Edelman.
The information is then sent to your cell phone. If you’re away from your phone, the sensor can give body alerts, a vibration telling you when your sugar is high or low.
“Having the comfort alert and alarm system 24/7 allows less stress and worry of hypoglycemia,” said Edelman.
Doctors say patients with diabetes can benefit greatly with Continuous Glucose Monitoring, but underused, and this is one more options patients can consider.
The Eversense CGM is for patients 18 or older and is intended to complement and not replace the finger stick blood glucose monitoring.